Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 22.71%444.78K | -10.91%387.79K | 10.69%484.39K | -20.23%1.66M | 15.01%421.47K | -30.53%362.47K | -33.58%435.27K | -17.98%437.62K | 25.73%2.08M | -26.62%366.47K |
| Operating revenue | 22.71%444.78K | -10.91%387.79K | 10.69%484.39K | -20.23%1.66M | 15.01%421.47K | -30.53%362.47K | -33.58%435.27K | -17.98%437.62K | 25.73%2.08M | -26.62%366.47K |
| Cost of revenue | 33.92%249.17K | -7.96%214K | 4.64%250.72K | -21.87%878.38K | 9.01%220.21K | -35.80%186.06K | -34.58%232.49K | -13.53%239.61K | 36.63%1.12M | -24.00%202.01K |
| Gross profit | 10.88%195.61K | -14.30%173.79K | 18.01%233.67K | -18.29%778.44K | 22.37%201.25K | -23.96%176.41K | -32.40%202.78K | -22.80%198.01K | 14.91%952.64K | -29.60%164.46K |
| Operating expense | 10.97%163.09K | 19.12%200.55K | 2.78%161.1K | 6.38%621.4K | -7.01%149.35K | 5.99%146.96K | 19.73%168.36K | 8.66%156.73K | -10.72%584.12K | -43.90%160.61K |
| Selling and administrative expenses | 12.20%148.31K | 20.96%185.78K | 3.07%146.32K | 7.10%562.3K | -7.72%134.57K | 6.71%132.19K | 22.05%153.58K | 9.64%141.96K | -13.97%525.01K | -44.32%145.83K |
| -Selling and marketing expense | -23.43%9.37K | -48.06%13.64K | 8.03%15.04K | -42.73%65.12K | -26.20%12.7K | -54.51%12.23K | -28.37%26.27K | -57.75%13.92K | 2.49%113.72K | -47.75%17.21K |
| -General and administrative expense | 15.83%138.95K | 35.21%172.13K | 2.53%131.29K | 20.88%497.17K | -5.25%121.87K | 23.68%119.95K | 42.79%127.31K | 32.64%128.04K | -17.63%411.3K | -43.82%128.62K |
| Depreciation amortization depletion | 0.00%14.78K | 0.00%14.78K | 0.00%14.78K | -0.00%59.1K | -0.01%14.78K | 0.00%14.78K | 0.00%14.78K | 0.00%14.78K | 34.43%59.1K | -39.46%14.78K |
| -Depreciation and amortization | 0.00%14.78K | 0.00%14.78K | 0.00%14.78K | -0.00%59.1K | -0.01%14.78K | 0.00%14.78K | 0.00%14.78K | 0.00%14.78K | 34.43%59.1K | -39.46%14.78K |
| Operating profit | 10.44%32.52K | -177.75%-26.76K | 75.85%72.58K | -57.39%157.04K | 1,248.13%51.9K | -68.45%29.45K | -78.40%34.42K | -63.22%41.27K | 110.82%368.52K | 107.31%3.85K |
| Net non-operating interest income (expenses) | -60.63%3.3K | -36.41%5.96K | -25.91%6.48K | 59.66%34.93K | 8.83%8.43K | 33.22%8.39K | 55.31%9.38K | 462.72%8.74K | 467.55%21.88K | 468.89%7.74K |
| Non-operating interest income | -54.45%4.68K | -34.29%7.47K | -25.24%8.11K | 35.94%42.68K | 2.23%10.18K | 19.18%10.28K | 34.22%11.37K | 165.14%10.85K | 1,939.90%31.39K | 547.24%9.96K |
| Non-operating interest expense | -26.96%1.38K | -24.31%1.51K | -22.49%1.63K | -18.61%7.74K | -20.83%1.76K | -18.83%1.89K | -18.13%1.99K | -16.94%2.11K | 26.99%9.51K | -39.03%2.22K |
| Other net income (expenses) | 515.40%6.72K | -680.66%-18.95K | -73.55%2.06K | 792.08%22.45K | 537.95%13.01K | -118.38%-1.62K | 167.33%3.26K | 284.59%7.8K | -3.24K | -2.97K |
| Gain on sale of security | 515.40%6.72K | -680.66%-18.95K | -73.55%2.06K | 792.08%22.45K | 537.95%13.01K | -118.38%-1.62K | 167.33%3.26K | 284.59%7.8K | ---3.24K | ---2.97K |
| Income before tax | 17.45%42.54K | -184.46%-39.75K | 40.31%81.11K | -44.62%214.43K | 750.48%73.34K | -66.60%36.22K | -70.69%47.06K | -47.23%57.81K | 129.29%387.16K | 115.74%8.62K |
| Income tax | 61.40%15.54K | -90.77%1.15K | 40.24%21.52K | -44.50%56.9K | 593.50%19.43K | -65.98%9.63K | -70.65%12.5K | -46.79%15.35K | 30.23%102.52K | -85.44%2.8K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 1.54%27K | -218.33%-40.9K | 40.34%59.59K | -44.66%157.53K | 826.00%53.91K | -66.81%26.59K | -70.70%34.56K | -47.39%42.46K | 215.81%284.64K | 107.86%5.82K |
| Net income continuous operations | 1.54%27K | -218.33%-40.9K | 40.34%59.59K | -44.66%157.53K | 826.00%53.91K | -66.81%26.59K | -70.70%34.56K | -47.39%42.46K | 215.81%284.64K | 107.86%5.82K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 1.54%27K | -218.33%-40.9K | 40.34%59.59K | -44.66%157.53K | 826.00%53.91K | -66.81%26.59K | -70.70%34.56K | -47.39%42.46K | 215.81%284.64K | 107.86%5.82K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 1.54%27K | -218.33%-40.9K | 40.34%59.59K | -44.66%157.53K | 826.00%53.91K | -66.81%26.59K | -70.70%34.56K | -47.39%42.46K | 215.81%284.64K | 107.86%5.82K |
| Diluted earnings per share | 0 | 0 | 0 | 0.00%0.01 | 0 | 0 | 0 | 0 | 0.00%0.01 | 0 |
| Basic earnings per share | 0 | 0 | 0 | 0.00%0.01 | 0 | 0 | 0 | 0 | 0.00%0.01 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.